How to Work in Europe and Beyond24th September 2015Chemical Industries Association

Agenda

Mark Treherne – Chief Executive of UKTI Life Sciences Organisation

Ajay Patel - Director of Recruitment & Staffing Mid Europe Region, MSD

Stuart Marquis, Liberty Bishop

New Scientist Jobs: Sponsors of the event

Panel Discussion

Closing remarks and depart

3

Unlock Your Global Business Potential: The UK Life Science Offer

4

THE UK HAS THE MOST OPEN AND BUSINESS-ORIENTATED ECONOMY OF EUROPE, WITH THE MOST FLEXIBLE LABOUR MARKETS, AND THE LEAST RESTRICTIVE SYSTEMS

Unlock Your Global Business Potential:The UK Life Science Offer

REC Life Sciences Event 24th September, 2015

Unlock Your Global Business Potential: The UK Life Science Offer

Government’s Commitment to the Life Science Sector

“In December 2011 I made a firm commitment to re-establish the UK's global leadership in the life science sector, announcing the Government's ten-year Strategy for UK Life Sciences.”

“By more closely integrating the UK's unique strengths, I believe that we can improve healthcare for patients, attract new investment to the UK, and create new jobs and business opportunities in an increasingly competitive and international industry.”

David CameronPrime Minister

5

The Strategy makes the most of the UK’s core strengths:

Basic science in universities Translational and clinical research Industry The National Health Service (NHS)

Unlock Your Global Business Potential: The UK Life Science Offer

The UK Ecosystem: Connect, Research, Develop, Validate, and Export

This increasingly integrated ecosystem is underpinned by a:

Supportive business environment

Open and flexible regulatory framework

Simplified industry access points

Unlock Your Global Business Potential: The UK Life Science Offer

UK Science: A Rich Heritage, Vibrant Research Base, and Investments for the Future

The UK has a rich heritage of life science discovery that has transformed scientific knowledge and continues to unlock clinical and commercial opportunities

77 Nobel Prizes and counting for contributions to biomedical science: from the building blocks of the new genomic age to the secrets of cells, to the physics that underpin magnetic resonance imaging (MRI)

World-class science + protected science budgetMajor research funding from the Medical Research Council and research charities like the Wellcome Trust and Cancer Research UK

In 2012, significant investment were made in next-gen science including genomics, synthetic biology, bioinformatics, and stem cells and regenerative medicineSupport from the Technology Strategy Board and the Biomedical Catalyst to translate science into new products and services

Present

Future

Past

Unlock Your Global Business Potential: The UK Life Science Offer

Building a Collaborative Research Ecosystem: Active PartnershipThe UK actively encourages research partnerships between academia, industry, and the NHS:

In Northern Ireland, Northern Ireland’s Connected Health and Prosperity Action Plan ensures cross sectorial support for health & social care R&D, innovation and widespread deployment of healthcare technologies.

In Wales, the National Institute for Social Care and Health Research Academic Health Science Collaboration maximises links between health boards , trusts, universities and industry to facilitate high quality research and improve healthcare.

Scotland, the Scottish Academic Health Sciences Collaboration facilitates partnerships between Scottish universities and health boards. This offers industry a coordinated system to contract and cost research studies across Scotland.

In England, five Academic Health Science Centres open up routes to market, supporting the development of new therapies and techniques

Unlock Your Global Business Potential: The UK Life Science Offer

Life Sciences Organisation – Recording Increased Results

LSO is tasked each year with delivering on key investment projects and targets and focuses on bringing value adding investment to the UK. There has been a consistent increase in inward investment over the past three years.Results for 2014/15: UK confirmed as the #1 destination for FDI in Europe LSO and our partners helped more than 180 businesses invest in the UK, creating more

than 5,500 new jobs and more than £2.2bn in new investment 20% of projects were linked to European, international or global headquarters functions 25% were linked to manufacturing Nearly half involved R&D From inception to March 15: £3.7bn investment and over 11,000 new jobs

This year, LSO will continue to focus on value-adding inward investment, attracting investment in priority subsectors and project themes, and enhancing our emphasis on Export Oriented FDI. Sources: UKTI Annual Inward Investment Report and UKTI LSO data

• Strong confidence in UK market is reflected in recent IPO activity reaching £408 million in 2014, with a further two IPOs in 2015

• Good stock market performance of new entrants, including 247% share gain by 4D Pharma since its IPO, helping to highlight the benefits of investing in the sector

• Increase in exits (via IPO and trade sales) have created a 10 year record in venture funding: investment in 2014 is up 71% to $430 million (2013: $251 million)

• UK is holding its own against the US and outperforming Europe in the past five years for venture funding

Public Markets

Source: BIA

Top 5 Public Investments 2013-2015

Source: EvaluatePharma® May 2015

UK Biotech VC annual data by round 2010-2014

Source: EvaluatePharma® May 2015

• UK Life science has recovered as an investment class

Why invest in the UK Life Science Sector?

Source: Venture Market Index

• Historical situation:

Who invests in the UK Sector?

Redrawn from Ford & Nelsen “The view beyond venture capital” Nature Biotech Dec 13

• Current situation:

Who invests in the UK Sector?

Redrawn from Ford & Nelsen “The view beyond venture capital” Nature Biotech Dec 13

• Need to understand the investor imperatives• Pure financial• Purely strategic• Somewhere between the two

• It is possible to make money in the UK but history suggests most UK funds have not beaten alternative investment classes to date

• Government support can support investment• The UK may be the largest, most dynamic market

after the US

Why invest in the UK Life Science Sector?

How is the investment process changing?

Note: CVC and VC investments by stage (% of companies, 2007 – 2011) All Sectors.

Unlock Your Global Business Potential: The UK Life Science Offer

How UK Trade & Investment (UKTI) Can Help Your Business

Our practical help and advice is free and confidential

UKTI’s professional trade and industry advisers operate in the UK alongside a global network of experts based in all British diplomatic offices overseas.

UKTI can: Provide tailored information on the UK offer and capabilities that match your business needs Support your business journey to invest in and grow in the UK

UKTI’s Life Sciences Organisation (LSO)The LSIO is here to help your business navigate the opportunity to partner with and invest in the UK and to connect you to wider UK life science community

For further details on the LSO and the UK life sciences offer for industry, visit: www.ukti.gov.uk/lifesciences

Unlock Your Global Business Potential: The UK Life Science Offer

19

THE UK HAS THE MOST OPEN AND BUSINESS-ORIENTATED ECONOMY OF EUROPE, WITH THE MOST FLEXIBLE LABOUR MARKETS, AND THE LEAST RESTRICTIVE SYSTEMS

Thank you

People Matter!

MSD

REC ConferenceSeptember 24th 2015

20

MSD Recruitment & Staffing

Agency Consulting Outsourcing In HouseEducation

Ajay Patel Associate Director, Recruitment & Staffing Mid Europe

Started career in Pharma / Science recruitmentCorporate, Global and Country level recruitmentManufacturing, Research, Development, Global FunctionsAgency Consulting, RPO (outsourcing), in house recruitment

BSc Physics with Astrophysics

2001 2009 2014

MSD Recruitment & StaffingMSD Sourcing Challenges

MSD Sourcing ChallengesExternal macro environment is changing:

Demographics quickly evolving.Governments address demands of > cost of healthcare.Our customers and their needs are changing.

MSD is transforming: Launching in new therapy areas, e.g. Oncology, HCV. We need to hire new / rare skillsets

to enable transformation to compete in new therapy areas.

Talent Acquisition is changing: There is a very real “War for Talent” in the pharma industry and we are not currently set

up to compete effectively.

... we need to evolve our

Sourcing Model

MSD Recruitment & StaffingMSD Europe & Canada Hiring

Direct Applications44%

Temp to Perm20%

Agency10%

Employee Referral3%

External DB Search6%

Social Media Search6%

Advertising7%

Social Media Advertising4%

MSD Europe & Canada2015 Number of External Hires per annum = Approx. 1200

Source Mix

MSD Recruitment & StaffingWhat % of niche external candidates can MSD see?

MSD Careers website advertising“Post and Pray”

Taleo Database MiningHM / Employee Referrals

Social Media SoucingLinkedIn, Xing, Facebook, Blogs

Advanced Boolean Search

Telephone Networking / Referrals

10%25%60% 45%80%

We see less than

15% of the external candidate

population today.

Low visibility = Low Choice= Low Quality

% V

isibi

lity

of a

ll ca

ndid

ates

in m

arke

tpla

ce

MSD Recruitment & Staffing

MSD Business Critical Needs in 2016

Functional AreaMedical AffairsMarket AccessMarketing / CommercialSupply Chain

Planned LaunchesOncology HEP C HIV

“Future Leaders”

MSD Recruitment & StaffingEUCAN Sourcing Hub

Launch of MSD EUCAN Sourcing Hub

EUCAN region volume is approx. 1200 external hires / annum

• RPO Sourcing Hub focus on 375 reqs / annum (prioritize critical skillsets)• Build basic agency capability in house with “Recruiter / Sourcer model”

5 x RPO Sourcers0.5 x RPO ManagerOffsite in Warsaw, Poland

RPO Resources

MM

D

ONC

O

1. Longlisting2. Longlisting + Qualification3. Longlisting + Qualification + Interview4. Market Intelligence Reports

RPO Sourcing “Packages”

MSD Recruitment & StaffingThere is still a need for strong agencies …

Why Would I Engage A Recruitment Agency?

Credibility in sourcing strategy presented to Hiring Manager

Bringing Market Intelligence to the conversation

Security of knowing a trusted Agency will deliver in a specific timeframe

Pipelining talent for confidential / business critical roles

Fast Access to existing database of candidate relationships

“Local Knowledge” in a specific country based market

Capacity extension for existing in house recruiter team

Business critical projects / growth strategy

Bring somethingthat I can’t

achieve in house!

MSD Recruitment & StaffingThere is a need for strong agencies in the EU…

Observations / Opportunities in Europe

European Agency market is relatively empty in many key markets

There is a gap for “Local” credible specialists in niche areasSome UK Agencies setting up local offices in EULanguage skills are important!

Remote UK Recruiters:Hard to pick to good from the badUK Agencies are seen as “aggressive”UK Agencies employ varied marketing strategiesIn house team will actively avoid calls from UK numbers!

An Agency Brand is only as good as your individual Recruiter servicing the Client

Good Afternoon… I’m Stuart Marquis from

… with thanks to you for your time, and to

Thursday 24th September 2015

Who are Liberty Bishop?We provide contractors with Umbrella and Limited Company services in the UK, as

well as providing payroll solutions for contractors working internationally.

• Established in 1995 – We have an in-depth understanding of your needs and those of your contractors

• Compliance – We ensure that all areas of compliance are adhered to in order to reduce risk to you, your clients, and your candidates

• We are “people NOT portals” and offering a highly personal service

Topic discussion:

“International Contractor Compliance”

Some General Methodological Principles

Correct Understanding of the 183 Day Ruling:

• Refers to the issue of tax residency, but that’s not the issue of primary importance

• Difference between non-resident and resident largely irrelevant with respect to tax due on local income

• Primary driver for where tax is due = where the work is being carried out

Some General Methodological Principles (continued)

The A1 route and its potential limitations:

• Problematic for one-man-band Ltd company contractors

• Payroll providers relying on this model unable to assist a wider spectrum of workers

International Solutions

We’ll now cover a brief overview for the following locations:

France (60-73% retention

Germany (50-64%) retention

The Netherlands

(60-65% retention)

Ireland50-65% retention

Sweden (50-68% retention)

Germany

• Labour leasing license (AUG) • German ID number and Tax Card

• Health Insurance requirement

• Wage Tax and Social Security

The Netherlands

• Dutch Chamber of Commerce

• Dutch wage Tax and Social Security

• 30% Ruling allowance

• Collective Labour Agreement

• G-Accounts

Sweden

• Swedish ID Number

• SA Tax

• SINK Tax

Ireland

• PPS number (Personal Public Service)

• Irish Income Tax Card

• PAYE and PRSI (Pay Related Social Insurance)

France

• PPS number (Personal Public Service)

• Irish Income Tax Card

• PAYE and PRSI (Pay Related Social Insurance)

Concluding Remarks

• Local registration from day one

• Deduction of local tax and social security, except where A1 applies

I would just like to say…

Any Questions please feel free to ask…

For all the latest news & updatesplease follow:

Panel Discussion

Thank you for coming

Next event: Scale up for High Skills, 10th November,REC Offices